My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

DexCom, Inc. - Common Stock (NQ:DXCM)

70.02 +4.94 (+7.59%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about DexCom, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

33 34 Next >

Why NASDAQ:DXCM Is a Promising High-Growth Stock in the Midst of Consolidation. ↗

October 16, 2024

Why DEXCOM INC (NASDAQ:DXCM) Is a Standout High-Growth Stock in a Consolidation Phase.

Via Chartmill

2 Magnificent Stocks to Buy That Are Near 52-Week Lows ↗

October 12, 2024

A discounted stock can present an opportunity when there's a quality business behind it.

Via The Motley Fool

Looking Into DexCom's Recent Short Interest ↗

October 09, 2024

Via Benzinga

Down More Than 50% From Its High, Is DexCom Stock a Buy? ↗

October 09, 2024

Is DexCom's business in trouble, or could this be a great buying opportunity for investors?

Via The Motley Fool

$100 Invested In This Stock 15 Years Ago Would Be Worth $3,600 Today ↗

October 08, 2024

Via Benzinga

2 Beaten-Down Growth Stocks You Might Regret Not Buying ↗

October 05, 2024

Their headwinds won't last forever.

Via The Motley Fool

$100 Invested In DexCom 15 Years Ago Would Be Worth This Much Today ↗

September 30, 2024

Via Benzinga

What the Options Market Tells Us About DexCom ↗

September 26, 2024

Via Benzinga

Is DexCom a Millionaire Maker? ↗

September 25, 2024

It isn't the most likely candidate to make someone a millionaire, but it's theoretically possible.

Via The Motley Fool

NASDAQ:DXCM, a strong growth stock, setting up for a breakout. ↗

September 19, 2024

Exploring the Growth Potential of DEXCOM INC (NASDAQ:DXCM) as It Nears a Breakout.

Via Chartmill

Is DexCom a Millionaire Maker? ↗

October 05, 2024

The company's game-changing technology could improve the lives of hundreds of millions of patients.

Via The Motley Fool

Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers. ↗

October 03, 2024

Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain.

Via Investor's Business Daily

Topics Stocks

Down More Than 50%, Is DexCom Stock a Bargain Now? ↗

October 02, 2024

Demand for blood glucose monitors is strong, but DexCom isn't the only competitor in this lucrative market.

Via The Motley Fool

2 Magnificent Growth Stocks Down 45% and 32% to Buy Right Now ↗

September 30, 2024

Sometimes, a discounted stock can present a valuable opportunity.

Via The Motley Fool

DexCom Is Great. Here's Why You Shouldn't Buy It. ↗

September 25, 2024

Two key uncertainties make the prospect of buying it today riskier than is desirable.

Via The Motley Fool

$100 Invested In DexCom 15 Years Ago Would Be Worth This Much Today ↗

September 09, 2024

Via Benzinga

Is DexCom a Millionaire-Maker Stock? ↗

September 02, 2024

The stock has delivered superior returns in the past 19 years.

Via The Motley Fool

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $38,000 Today ↗

August 27, 2024

Via Benzinga

Uh-Oh! Alphabet Is Selling Its Stake in 2 Historically High-Flying Artificial Intelligence (AI) Stocks ↗

September 17, 2024

These once-sizable artificial intelligence (AI) holdings for Google parent Alphabet have been paired down big-time over the last two quarters.

Via The Motley Fool

Topics Artificial Intelligence

2 Unstoppable Healthcare Stocks to Buy Right Now for Less Than $200 ↗

September 14, 2024

No need to break the bank to get in on these excellent companies.

Via The Motley Fool

3 Reasons DexCom Looks Like a No-Brainer Buy Right Now ↗

September 12, 2024

The stock isn't normally this cheap, and investors should take advantage.

Via The Motley Fool

Jim Cramer Doesn't Like Carnival Right Now: Royal Caribbean Is 'The One You Want' ↗

September 06, 2024

Royal Caribbean has "the best systems right now," Jim Cramer says. "It's got the best numbers. It's the one you want, not Carnival."

Via Benzinga

Abbott's 'Transformative' Move And Answer To Dexcom's Newest Device ↗

September 05, 2024

The companies are now duking it out for a new population of CGM users.

Via Investor's Business Daily

Why NASDAQ:DXCM Is a Promising High-Growth Stock in the Midst of Consolidation. ↗

August 27, 2024

DEXCOM INC (NASDAQ:DXCM): a strong growth stock preparing for the next leg up?.

Via Chartmill

Decoding 18 Analyst Evaluations For DexCom ↗

August 23, 2024

Via Benzinga

Dexcom's Stelo Device Brings Affordable Continuous Glucose Monitoring To Type 2 Diabetes Patients ↗

August 26, 2024

DexCom's Stelo Glucose Biosensor System, the first over-the-counter continuous glucose monitor, is now available without a prescription. Designed for people with Type 2 diabetes and prediabetes, Stelo...

Via Benzinga

Will New 'Milestone' Glucose Monitor Help Dexcom Stock Bounce Back? ↗

August 26, 2024

The company is upbeat on its upcoming Stelo launch. The CGM is geared to people who don't use insulin.

Via Investor's Business Daily

Is It Time to Buy July's Worst-Performing S&P 500 Stocks? ↗

August 21, 2024

These stocks took a dive recently, and that could spell opportunity.

Via The Motley Fool

Topics Stocks

S&P 500, Nasdaq 100 Snap 8-Day Winning Streak: What Triggered Wall Street's Setback On Tuesday? ↗

August 20, 2024

S&P 500 ended Tuesday's session with slight declines, halting its best winning streak since May 2024. Here's the latest.

Via Benzinga

Topics Stocks

S&P 500, Nasdaq Look To Snap Best Win Streaks Of 2024 ↗

August 20, 2024

Stocks are taking a breather, with the S&P 500 Index and Nasdaq Composite Index firmly lower this afternoon after yesterday nabbing their eighth-straight gains and best win streaks of the year.

Via Talk Markets

Topics Stocks

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

33 34 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.